Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
American Journal of Respiratory Cell and Molecular Biology|October 3, 2002
Association of genetic defects in primary resected lung adenocarcinoma revealed by targeted allelic imbalance analysisFlorence Cave-Riant, Benoit Cuillerier, Michèle Beau-Faller, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|November 6, 2010
Mapping EGFR1 mutations in patients with lung adenocarcinomaFotis Vlastos, Julie Zinszner, Thomas Hussenet, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2016
Synthesis of a selective HDAC6 inhibitor active in neuroblastsVincent Zwick, Claudia A Simões-Pires, Alessandra Nurisso, et al.
Plos One|February 4, 2010
SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomasThomas Hussenet, Soraya Dali, Julien Exinger, et al.
Oncogene|July 12, 2005
The retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycleMichaël Jeanblanc, Marc Mousli, Raphaël Hopfner, et al.
Virchows Archiv : an International Journal of Pathology|May 4, 2013
Retinoid acid receptor expression is helpful to distinguish between adenoma and well-differentiated carcinoma in the thyroidGuillaume Gauchotte, Stéphanie Lacomme, Lydia Brochin, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2014
Aurones as histone deacetylase inhibitors: identification of key featuresVincent Zwick, Alkiviadis-Orfefs Chatzivasileiou, Nathalie Deschamps, et al.
ACS Medicinal Chemistry Letters|April 20, 2018
Imidazo[2,1-b]benzothiazol Derivatives as Potential Allosteric Inhibitors of the Glucocorticoid ReceptorMichael S Christodoulou, Federico Dapiaggi, Francesca Ghiringhelli, et al.
Bioorganic & Medicinal Chemistry|October 10, 2013
Quinazolinecarboline alkaloid evodiamine as scaffold for targeting topoisomerase I and sirtuinsMichael S Christodoulou, Alessandro Sacchetti, Valentina Ronchetti, et al.
European Journal of Medicinal Chemistry|January 28, 2015
Boehmeriasin A as new lead compound for the inhibition of topoisomerases and SIRT2Michael S Christodoulou, Francesco Calogero, Marcus Baumann, et al.
Pageof 4